Legal questions swirl around FDA's new expedited drug program, including who should sign off

The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald ...

Takeaways From the AP's Report on Turmoil Surrounding the FDA's New Fast-Track Drug Program

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...

Some drugmakers quietly concerned about legal risk with speedy FDA review program

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...